European Cancer Congress
27 September 2013 - 01 October 2013
The 17th ECCO – 38th ESMO – 32nd ESTRO European Cancer Congress is organised in partnership with ESSO 33, EACR, EONS and SIOPE. The European Cancer Congresses are consequently the only multidisciplinary and multi-professional educational opportunity in oncology to take place in Europe – a fact that underpins the relevance, role and participation of each and every speciality in oncology.
Thanks to this multidisciplinary collaboration, oncology professionals and patient advocates alike will be able to see and learn from the tangible benefits of cancer disciplines working together, with active patient involvement at the heart of discussions.
Amsterdam, Netherlands
http://www.esmo.org/Conferences/European-Cancer-Congress-2013
13th Annual Biotech in Europe Investor Forum
30 September 2013 - 01 October 2013
The forum is recognised as the leading international stage for those interested in investing in the biotech and life science industry and is highly transactional, drawing together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharmas. Supported and designed by leading figures within Europe’s bio industry, this event will once again be covered by our regular media partners. We expect around 350 delegates and 80 presenting companies.
Hilton Zurich Airport Hotel, Zurich, Switzerland
http://www.sandtiger.co.uk/zurich13/registration-enquiry.php
Diabetes
01 October 2013 - 02 October 2013
Now at epidemic levels, diabetes will affect eight percent of the world’s adult population by 2030. As the number of diabetics grows, so too will the need for new treatments to mitigate the effects of diabetes-related disorders and diseases. With this in mind, SMi is very proud to present our 11th conference focusing on Diabetes, Secondary Complications, Regulation and Innovation. The conference will take place on the 1st and 2nd October 2013 and will provide a unique platform to engage with industry professionals, KOLs and esteemed academia in the field of diabetic and metabolic disease. With a spotlight on areas such as: combination therapy, diabetic retinopathy, stem cell and islet technology and EU and FDA guidelines, Diabetes 2013 promises to be a truly unmissable event!
Marriott Hotel, Regents Park, London, UK
http://www.smi-online.co.uk/pharmaceuticals/uk/conference/diabetes?utm_source=P-082&utm_medium=EM%20-%20PM&utm_campaign=GroupMail
Molecular Life Sciences 2013
03 October 2013 - 06 October 2013
Leading experts from all current biochemical fields will present their work in plenary lectures at the Molecular Life Sciences. Also, the 17 GBM study groups have organized separate sessions with top speakers from abroad, local celebrities and newcomers.
Goethe University Frankfurt, Germany
http://www.molecular-life-sciences.de/
Biomarker Europe Summit 2013
09 October 2013 - 10 October 2013
The summit will address the latest developments in the biomarker arena from discovery to translation to commercialization. Presentations span across multiple disciplines and cover topics such as discovery and validation strategies, the challenges of clinical translation, novel technologies including next-generation sequencing, regulatory and reimbursement issues and companion diagnostics. Scientific data, case studies and discussions will be facilitated by key representatives from pharma, biotech, academia and the public sector.
Kempinski Hotel Bristol Berlin, Berlin, Germany
http://www.gtcbio.com/conference/biomarkers-europe-summit-overview
Academic Drug Discovery Conference 2013
09 October 2013 - 11 October 2013
The Academic Drug Discovery Conference is a unique environment, designed to bring together both industry and academic drug discovery scientists to help share best practices, new techniques, partnering and funding opportunities, while also ushering the next generation of drug discovery scientists into the fold with education and career opportunities. This conference was started by the Academic Drug Discovery Consortium, a group of now 76 academic drug discovery centers, and is being held in Nashville, Tennessee this October, 2013. We look forward to seeing you in October as we gather to accelerate the translation of basic drug research into new therapeutics.
Nashville, Tennessee, USA
http://www.addc2013.com/
Nordic Life Science Days
14 October 2013 - 15 October 2013
Nordic Life Science Days brings executives from small to medium sized Nordic life science companies to a global audience in the world’s highest ranking region for innovation. With the audience encompassing pharma, biotech, medtech, diagnostic, digital health companies, financing institutions and industry experts, Nordic Life Science Days is a focused, targeted and exceptional platform to explore the region’s expertise and investment and partnering opportunities.
The event, brought to you by SwedenBIO in conjunction with its sister organisations in Denmark, Finland and Norway, was inspired by the already popular Life Science Day Scandinavia, and for the first time, offers a stage on which to showcase latest innovation in Nordic countries, industry experts in sessions, panel discussions, and keynote formats.
Stockholm Waterfront Congress Centre
http://www.nlsdays.com/
Computational Aspects of High-Throughput Screening planning and analysis
14 October 2013 - 16 October 2013
This course is aimed at academic, not-for-profit, and industrial researchers who need to perform high-throughput screens (HTS) of small molecule compounds and then analyse the data that these screens generate. Using a combination of lectures, discussions and computer-based practical sessions, you will learn how to use computational tools for the design, refinement and analysis of high-throughput screen data. This course is funded in part by BioMedBridges and EU-OPENSCREEN which are developing resources to assist the exchange of research findings across Europe; linking chemical biology data with other biological data from clinical trials, biobanks and disease phenotypes.
EMBL Heidelberg, Germany
http://www.embl.de/training/events/2013/CHI13-01/
Orphan Drugs & Rare Diseases
14 October 2013 - 15 October 2013
Recent years have seen huge growth in orphan drug development, but also a time of increased pressure as many leading blockbuster drugs soon come off patent.
Join SMi for their 2nd Annual Orphan Drugs & Rare Diseases conference as they showcase world leading experts speaking inclusively on the orphan drug industry featuring cutting edge research via case studies taking place in previously untreatable patients. The conference will highlight current regulatory policies involving the FDA & EMA, new drug discoveries and partnerships in clinical trials and drug development with patient groups.
There will also be a 'big pharma spotlight session' highlighting where current pipelines stand and where the next blockbuster will be treating rare diseases, including discussions on HTA and pricing issues currently being implemented after recent reforms in Europe.
Marriott Regents Park, London, UK
http://www.smi-online.co.uk/pharmaceuticals/uk/conference/orphan-drugs-rare-diseases
Idea to IPO
17 October 2013 - 18 October 2013
Research Commercialisation is new cross-discipline partnering event aimed at providing senior level participants with a unique opportunity to make new commercial partnerships.
Attendees will include:
University deans
Technology transfer officers
Heads of R&D
Innovation and commercialisation officers
Senior scientists
Investors
Government advisors
Public and private funding agencies
MCE Conference Centre, Brussels, Belgium
http://www.idea2ipo-conference.com/index.html
Antibody & Protein Therapeutics
23 October 2013 - 25 October 2013
We invite you to join us at GTC’s inaugural Antibody & Protein Therapeutics Conference on October 23-25 in San Diego, CA. This conference strives to connect industry and academic researchers in the protein therapeutics field to facilitate discussion on the current state of the industry and discuss opportunities and challenges involved in therapeutic development.
Representatives from big pharma, academic institutions and government research labs will present data and case studies on key topics such as antibody drug conjugates, bispecific antibodies and overcoming the blood-brain barrier. Attend to learn and network with key opinion leaders in a highly interactive and intimate environment.
Paradise Point Resort & Spa, San Diego, CA
http://www.gtcbio.com/conference/antibody-protein-therapeutics-overview
Can Medicine Be Your Food?The challenging borderline between herbal medicines and botanicals
28 October 2013
A symposium exploring the borderline between herbal medicines and food supplements to be held at the Royal Botanic Gardens, Kew, London
Jodrell Laboratory, Royal Botanic Gardens, Kew, London, UK
http://bhma.info/index.php/registration/